Global CAR T-cell Therapy Drug Supply, Demand and Key Producers, 2023-2029

Page: 102

Published Date: 03 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global CAR T-cell Therapy Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
This report studies the global CAR T-cell Therapy Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for CAR T-cell Therapy Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CAR T-cell Therapy Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global CAR T-cell Therapy Drug total market, 2018-2029, (USD Million)
Global CAR T-cell Therapy Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CAR T-cell Therapy Drug total market, key domestic companies and share, (USD Million)
Global CAR T-cell Therapy Drug revenue by player and market share 2018-2023, (USD Million)
Global CAR T-cell Therapy Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global CAR T-cell Therapy Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global CAR T-cell Therapy Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics and FOSUNKite, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CAR T-cell Therapy Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global CAR T-cell Therapy Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global CAR T-cell Therapy Drug Market, Segmentation by Type
    CD19-targeted
    BCMA-targeted

Global CAR T-cell Therapy Drug Market, Segmentation by Application
    Lymphoma
    Multiple Myeloma

Companies Profiled:
    Novartis
    Gilead Sciences
    Bristol-Myers Squibb
    J & J
    JW Therapeutics
    FOSUNKite

Key Questions Answered
1. How big is the global CAR T-cell Therapy Drug market?
2. What is the demand of the global CAR T-cell Therapy Drug market?
3. What is the year over year growth of the global CAR T-cell Therapy Drug market?
4. What is the total value of the global CAR T-cell Therapy Drug market?
5. Who are the major players in the global CAR T-cell Therapy Drug market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 CAR T-cell Therapy Drug Introduction
    1.2 World CAR T-cell Therapy Drug Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World CAR T-cell Therapy Drug Total Market by Region (by Headquarter Location)
        1.3.1 World CAR T-cell Therapy Drug Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States CAR T-cell Therapy Drug Market Size (2018-2029)
        1.3.3 China CAR T-cell Therapy Drug Market Size (2018-2029)
        1.3.4 Europe CAR T-cell Therapy Drug Market Size (2018-2029)
        1.3.5 Japan CAR T-cell Therapy Drug Market Size (2018-2029)
        1.3.6 South Korea CAR T-cell Therapy Drug Market Size (2018-2029)
        1.3.7 ASEAN CAR T-cell Therapy Drug Market Size (2018-2029)
        1.3.8 India CAR T-cell Therapy Drug Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 CAR T-cell Therapy Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 CAR T-cell Therapy Drug Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World CAR T-cell Therapy Drug Consumption Value (2018-2029)
    2.2 World CAR T-cell Therapy Drug Consumption Value by Region
        2.2.1 World CAR T-cell Therapy Drug Consumption Value by Region (2018-2023)
        2.2.2 World CAR T-cell Therapy Drug Consumption Value Forecast by Region (2024-2029)
    2.3 United States CAR T-cell Therapy Drug Consumption Value (2018-2029)
    2.4 China CAR T-cell Therapy Drug Consumption Value (2018-2029)
    2.5 Europe CAR T-cell Therapy Drug Consumption Value (2018-2029)
    2.6 Japan CAR T-cell Therapy Drug Consumption Value (2018-2029)
    2.7 South Korea CAR T-cell Therapy Drug Consumption Value (2018-2029)
    2.8 ASEAN CAR T-cell Therapy Drug Consumption Value (2018-2029)
    2.9 India CAR T-cell Therapy Drug Consumption Value (2018-2029)

3 World CAR T-cell Therapy Drug Companies Competitive Analysis
    3.1 World CAR T-cell Therapy Drug Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global CAR T-cell Therapy Drug Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for CAR T-cell Therapy Drug in 2022
        3.2.3 Global Concentration Ratios (CR8) for CAR T-cell Therapy Drug in 2022
    3.3 CAR T-cell Therapy Drug Company Evaluation Quadrant
    3.4 CAR T-cell Therapy Drug Market: Overall Company Footprint Analysis
        3.4.1 CAR T-cell Therapy Drug Market: Region Footprint
        3.4.2 CAR T-cell Therapy Drug Market: Company Product Type Footprint
        3.4.3 CAR T-cell Therapy Drug Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: CAR T-cell Therapy Drug Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: CAR T-cell Therapy Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: CAR T-cell Therapy Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: CAR T-cell Therapy Drug Consumption Value Comparison
        4.2.1 United States VS China: CAR T-cell Therapy Drug Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: CAR T-cell Therapy Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based CAR T-cell Therapy Drug Companies and Market Share, 2018-2023
        4.3.1 United States Based CAR T-cell Therapy Drug Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies CAR T-cell Therapy Drug Revenue, (2018-2023)
    4.4 China Based Companies CAR T-cell Therapy Drug Revenue and Market Share, 2018-2023
        4.4.1 China Based CAR T-cell Therapy Drug Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies CAR T-cell Therapy Drug Revenue, (2018-2023)
    4.5 Rest of World Based CAR T-cell Therapy Drug Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based CAR T-cell Therapy Drug Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies CAR T-cell Therapy Drug Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World CAR T-cell Therapy Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 CD19-targeted
        5.2.2 BCMA-targeted
    5.3 Market Segment by Type
        5.3.1 World CAR T-cell Therapy Drug Market Size by Type (2018-2023)
        5.3.2 World CAR T-cell Therapy Drug Market Size by Type (2024-2029)
        5.3.3 World CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World CAR T-cell Therapy Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Lymphoma
        6.2.2 Multiple Myeloma
    6.3 Market Segment by Application
        6.3.1 World CAR T-cell Therapy Drug Market Size by Application (2018-2023)
        6.3.2 World CAR T-cell Therapy Drug Market Size by Application (2024-2029)
        6.3.3 World CAR T-cell Therapy Drug Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Details
        7.1.2 Novartis Major Business
        7.1.3 Novartis CAR T-cell Therapy Drug Product and Services
        7.1.4 Novartis CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Novartis Recent Developments/Updates
        7.1.6 Novartis Competitive Strengths & Weaknesses
    7.2 Gilead Sciences
        7.2.1 Gilead Sciences Details
        7.2.2 Gilead Sciences Major Business
        7.2.3 Gilead Sciences CAR T-cell Therapy Drug Product and Services
        7.2.4 Gilead Sciences CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Gilead Sciences Recent Developments/Updates
        7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.3 Bristol-Myers Squibb
        7.3.1 Bristol-Myers Squibb Details
        7.3.2 Bristol-Myers Squibb Major Business
        7.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Product and Services
        7.3.4 Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Bristol-Myers Squibb Recent Developments/Updates
        7.3.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.4 J & J
        7.4.1 J & J Details
        7.4.2 J & J Major Business
        7.4.3 J & J CAR T-cell Therapy Drug Product and Services
        7.4.4 J & J CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 J & J Recent Developments/Updates
        7.4.6 J & J Competitive Strengths & Weaknesses
    7.5 JW Therapeutics
        7.5.1 JW Therapeutics Details
        7.5.2 JW Therapeutics Major Business
        7.5.3 JW Therapeutics CAR T-cell Therapy Drug Product and Services
        7.5.4 JW Therapeutics CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 JW Therapeutics Recent Developments/Updates
        7.5.6 JW Therapeutics Competitive Strengths & Weaknesses
    7.6 FOSUNKite
        7.6.1 FOSUNKite Details
        7.6.2 FOSUNKite Major Business
        7.6.3 FOSUNKite CAR T-cell Therapy Drug Product and Services
        7.6.4 FOSUNKite CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 FOSUNKite Recent Developments/Updates
        7.6.6 FOSUNKite Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 CAR T-cell Therapy Drug Industry Chain
    8.2 CAR T-cell Therapy Drug Upstream Analysis
    8.3 CAR T-cell Therapy Drug Midstream Analysis
    8.4 CAR T-cell Therapy Drug Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World CAR T-cell Therapy Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World CAR T-cell Therapy Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World CAR T-cell Therapy Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World CAR T-cell Therapy Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World CAR T-cell Therapy Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World CAR T-cell Therapy Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World CAR T-cell Therapy Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World CAR T-cell Therapy Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World CAR T-cell Therapy Drug Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key CAR T-cell Therapy Drug Players in 2022
    Table 12. World CAR T-cell Therapy Drug Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global CAR T-cell Therapy Drug Company Evaluation Quadrant
    Table 14. Head Office of Key CAR T-cell Therapy Drug Player
    Table 15. CAR T-cell Therapy Drug Market: Company Product Type Footprint
    Table 16. CAR T-cell Therapy Drug Market: Company Product Application Footprint
    Table 17. CAR T-cell Therapy Drug Mergers & Acquisitions Activity
    Table 18. United States VS China CAR T-cell Therapy Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China CAR T-cell Therapy Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based CAR T-cell Therapy Drug Companies, Headquarters (States, Country)
    Table 21. United States Based Companies CAR T-cell Therapy Drug Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies CAR T-cell Therapy Drug Revenue Market Share (2018-2023)
    Table 23. China Based CAR T-cell Therapy Drug Companies, Headquarters (Province, Country)
    Table 24. China Based Companies CAR T-cell Therapy Drug Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies CAR T-cell Therapy Drug Revenue Market Share (2018-2023)
    Table 26. Rest of World Based CAR T-cell Therapy Drug Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies CAR T-cell Therapy Drug Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies CAR T-cell Therapy Drug Revenue Market Share (2018-2023)
    Table 29. World CAR T-cell Therapy Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World CAR T-cell Therapy Drug Market Size by Type (2018-2023) & (USD Million)
    Table 31. World CAR T-cell Therapy Drug Market Size by Type (2024-2029) & (USD Million)
    Table 32. World CAR T-cell Therapy Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World CAR T-cell Therapy Drug Market Size by Application (2018-2023) & (USD Million)
    Table 34. World CAR T-cell Therapy Drug Market Size by Application (2024-2029) & (USD Million)
    Table 35. Novartis Basic Information, Area Served and Competitors
    Table 36. Novartis Major Business
    Table 37. Novartis CAR T-cell Therapy Drug Product and Services
    Table 38. Novartis CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Novartis Recent Developments/Updates
    Table 40. Novartis Competitive Strengths & Weaknesses
    Table 41. Gilead Sciences Basic Information, Area Served and Competitors
    Table 42. Gilead Sciences Major Business
    Table 43. Gilead Sciences CAR T-cell Therapy Drug Product and Services
    Table 44. Gilead Sciences CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Gilead Sciences Recent Developments/Updates
    Table 46. Gilead Sciences Competitive Strengths & Weaknesses
    Table 47. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 48. Bristol-Myers Squibb Major Business
    Table 49. Bristol-Myers Squibb CAR T-cell Therapy Drug Product and Services
    Table 50. Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Bristol-Myers Squibb Recent Developments/Updates
    Table 52. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 53. J & J Basic Information, Area Served and Competitors
    Table 54. J & J Major Business
    Table 55. J & J CAR T-cell Therapy Drug Product and Services
    Table 56. J & J CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. J & J Recent Developments/Updates
    Table 58. J & J Competitive Strengths & Weaknesses
    Table 59. JW Therapeutics Basic Information, Area Served and Competitors
    Table 60. JW Therapeutics Major Business
    Table 61. JW Therapeutics CAR T-cell Therapy Drug Product and Services
    Table 62. JW Therapeutics CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. JW Therapeutics Recent Developments/Updates
    Table 64. FOSUNKite Basic Information, Area Served and Competitors
    Table 65. FOSUNKite Major Business
    Table 66. FOSUNKite CAR T-cell Therapy Drug Product and Services
    Table 67. FOSUNKite CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 68. Global Key Players of CAR T-cell Therapy Drug Upstream (Raw Materials)
    Table 69. CAR T-cell Therapy Drug Typical Customers
List of Figure
    Figure 1. CAR T-cell Therapy Drug Picture
    Figure 2. World CAR T-cell Therapy Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World CAR T-cell Therapy Drug Total Market Size (2018-2029) & (USD Million)
    Figure 4. World CAR T-cell Therapy Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World CAR T-cell Therapy Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company CAR T-cell Therapy Drug Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company CAR T-cell Therapy Drug Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company CAR T-cell Therapy Drug Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company CAR T-cell Therapy Drug Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company CAR T-cell Therapy Drug Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company CAR T-cell Therapy Drug Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company CAR T-cell Therapy Drug Revenue (2018-2029) & (USD Million)
    Figure 13. CAR T-cell Therapy Drug Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World CAR T-cell Therapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 16. World CAR T-cell Therapy Drug Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States CAR T-cell Therapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 18. China CAR T-cell Therapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe CAR T-cell Therapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan CAR T-cell Therapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea CAR T-cell Therapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN CAR T-cell Therapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 23. India CAR T-cell Therapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of CAR T-cell Therapy Drug by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for CAR T-cell Therapy Drug Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for CAR T-cell Therapy Drug Markets in 2022
    Figure 27. United States VS China: CAR T-cell Therapy Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: CAR T-cell Therapy Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World CAR T-cell Therapy Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World CAR T-cell Therapy Drug Market Size Market Share by Type in 2022
    Figure 31. CD19-targeted
    Figure 32. BCMA-targeted
    Figure 33. World CAR T-cell Therapy Drug Market Size Market Share by Type (2018-2029)
    Figure 34. World CAR T-cell Therapy Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World CAR T-cell Therapy Drug Market Size Market Share by Application in 2022
    Figure 36. Lymphoma
    Figure 37. Multiple Myeloma
    Figure 38. CAR T-cell Therapy Drug Industrial Chain
    Figure 39. Methodology
    Figure 40. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global CAR T-cell Therapy Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global CAR T-cell Therapy Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 06 Feb 2023

date Pharma & Healthcare

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer

Global CAR T-cell Therapy Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global CAR T-cell Therapy Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 05 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global CAR T-cell Therapy Drug market size was valued at USD 2887 million in 2023 and is forecast to a readjusted size of USD 16810 million by 2030 with a CAGR of 28.6% during review period.

Global CAR T-cell Therapy Drug Supply, Demand and Key Producers, 2024-2030

Global CAR T-cell Therapy Drug Supply, Demand and Key Producers, 2024-2030

date 24 Feb 2024

date Pharma & Healthcare

The global CAR T-cell Therapy Drug market size is expected to reach $ 16810 million by 2030, rising at a market growth of 28.6% CAGR during the forecast period (2024-2030).

Product Tags

CAR T-cell Therapy Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>